A detailed history of Long Island Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Long Island Wealth Management, Inc. holds 1,045 shares of ABBV stock, worth $244,530. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,045
Holding current value
$244,530
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$184.85 - $231.54 $193,168 - $241,959
1,045 New
1,045 $242 Million
Q1 2025

May 13, 2025

BUY
$169.2 - $216.66 $170,553 - $218,393
1,008 New
1,008 $211 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $131,132 - $147,686
953 New
953 $148 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Long Island Wealth Management, Inc. Portfolio

Follow Long Island Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Island Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Long Island Wealth Management, Inc. with notifications on news.